Skip to main content
Client Work

Lungpacer Medical in its US$20 million Series B funding round

Fasken
Reading Time 1 minute read Subscribe

Overview

Client

Lungpacer Medical Inc.

Vancouver, Canada-based Lungpacer Medical Inc. raised US$20 million of Series B venture funding from WJFS and its existing lead investor 4CGE.

Lungpacer develops a diaphragm pacing therapy system (DPTS) to assist in weaning patients off mechanical ventilation who are determined by a healthcare provider to be at high risk of weaning failure.

Fasken represented Lungpacer Medical with a team led by Jon Conlin and included Steven Lumbala (Corporate Finance).
 

Jurisdiction

  • British Columbia

Team

    Subscribe

    Receive email updates from our team

    Subscribe